Anginex

General Information


DRACP ID  DRACP04820

Peptide Name   Anginex

Sequence  ANIKLSVQMKLFKRHLKWKIIVKLNDGRELSLDA

Sequence Length  34

UniProt ID  Not available

PubChem CID  Not available

Origin  PF4

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Galectin 1

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C183H310N52O46S

Absent amino acids  CPTY

Common amino acids  KL

Mass  459568

Pl  11.08

Basic residues  9

Acidic residues  3

Hydrophobic residues  15

Net charge  6

Boman Index  -5309

Hydrophobicity  -19.12

Aliphatic Index  126.18

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  166.67

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21470139

Title  Anti-angiogenic peptides for cancer therapeutics

Doi 10.2174/138920111796117300

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.